248 related articles for article (PubMed ID: 17088986)
21. Augmentation of antitumor activity of 5-fluorouracil by interferon alpha is associated with up-regulation of p27Kip1 in human hepatocellular carcinoma cells.
Eguchi H; Nagano H; Yamamoto H; Miyamoto A; Kondo M; Dono K; Nakamori S; Umeshita K; Sakon M; Monden M
Clin Cancer Res; 2000 Jul; 6(7):2881-90. PubMed ID: 10914738
[TBL] [Abstract][Full Text] [Related]
22. Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines.
Yano H; Iemura A; Haramaki M; Ogasawara S; Takayama A; Akiba J; Kojiro M
Hepatology; 1999 Jun; 29(6):1708-17. PubMed ID: 10347112
[TBL] [Abstract][Full Text] [Related]
23. [A case of combined hepatocellular and cholangiocarcinoma showing tumor growth and invasion to the diaphragm during interferon-alpha and 5-fluorouracil combined intra-arterial chemotherapy].
Noda T; Nagano H; Marubashi S; Kobayashi S; Takeda Y; Murakami M; Tomimaru Y; Dono K; Umeshita K; Nakayama M; Shima T; Wakasa K; Monden M; Doki Y; Mori M
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2099-102. PubMed ID: 19106536
[TBL] [Abstract][Full Text] [Related]
24. Activation of Wnt/beta-catenin signalling pathway induces chemoresistance to interferon-alpha/5-fluorouracil combination therapy for hepatocellular carcinoma.
Noda T; Nagano H; Takemasa I; Yoshioka S; Murakami M; Wada H; Kobayashi S; Marubashi S; Takeda Y; Dono K; Umeshita K; Matsuura N; Matsubara K; Doki Y; Mori M; Monden M
Br J Cancer; 2009 May; 100(10):1647-58. PubMed ID: 19401692
[TBL] [Abstract][Full Text] [Related]
25. PTK787/ZK222584 combined with interferon alpha and 5-fluorouracil synergistically inhibits VEGF signaling pathway in hepatocellular carcinoma.
Katsura Y; Wada H; Murakami M; Akita H; Hama N; Kawamoto K; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S517-26. PubMed ID: 23508585
[TBL] [Abstract][Full Text] [Related]
26. [A case of advanced hepatocellular carcinoma with lung metastases and cirrhosis that responded to combination chemotherapy with interferon-alpha and 5-fluorouracil].
Shitara K; Munakata M; Kudo T; Muto O; Okada R; Mitobe S; Sakata Y; Kondo M; Ishii E; Yabu K
Gan To Kagaku Ryoho; 2006 Dec; 33(13):2083-6. PubMed ID: 17197759
[TBL] [Abstract][Full Text] [Related]
27. A sequential treatment of depsipeptide followed by 5-azacytidine enhances Gadd45beta expression in hepatocellular carcinoma cells.
Jiang C; Zhou B; Fan K; Heung E; Xue L; Liu X; Kirschbaum M; Yen Y
Anticancer Res; 2007; 27(6B):3783-9. PubMed ID: 18225533
[TBL] [Abstract][Full Text] [Related]
28. The impact of interferon gamma receptor expression on the mechanism of escape from host immune surveillance in hepatocellular carcinoma.
Nagao M; Nakajima Y; Kanehiro H; Hisanaga M; Aomatsu Y; Ko S; Tatekawa Y; Ikeda N; Kanokogi H; Urizono Y; Kobayashi T; Shibaji T; Kanamura T; Ogawa S; Nakano H
Hepatology; 2000 Sep; 32(3):491-500. PubMed ID: 10960440
[TBL] [Abstract][Full Text] [Related]
29. Biochemical modulation of 5-fluorouracil with interferon alpha/beta and gamma on murine renal cell carcinoma.
Ishii T; Marumo K
Int J Urol; 2004 Nov; 11(11):993-1000. PubMed ID: 15509204
[TBL] [Abstract][Full Text] [Related]
30. A comparison of the antitumor effects of interferon-alpha and beta on human hepatocellular carcinoma cell lines.
Murata M; Nabeshima S; Kikuchi K; Yamaji K; Furusyo N; Hayashi J
Cytokine; 2006 Feb; 33(3):121-8. PubMed ID: 16522372
[TBL] [Abstract][Full Text] [Related]
31. Molecular prediction of response to 5-fluorouracil and interferon-alpha combination chemotherapy in advanced hepatocellular carcinoma.
Kurokawa Y; Matoba R; Nagano H; Sakon M; Takemasa I; Nakamori S; Dono K; Umeshita K; Ueno N; Ishii S; Kato K; Monden M
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6029-38. PubMed ID: 15447987
[TBL] [Abstract][Full Text] [Related]
32. [Development and research of the new therapy for hepatocellular carcinoma--combined interferon and 5-fluorouracil therapy].
Nagano H; Sakon M; Monden M
Nihon Rinsho; 2002 Nov; 60(11):2237-44. PubMed ID: 12440136
[TBL] [Abstract][Full Text] [Related]
33. A role for Janus kinases in crosstalk between ErbB3 and the interferon-alpha signaling complex in myeloma cells.
Walters DK; Jelinek DF
Oncogene; 2004 Feb; 23(6):1197-205. PubMed ID: 14647450
[TBL] [Abstract][Full Text] [Related]
34. [Intrahepatic arterial chemotherapy with 5-fluorouracil and intramuscular interferon-alpha for a patient with diffuse type of hepatocellular carcinoma].
Ochiai T; Sonoyama T; Kikuchi S; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ueda Y; Otsuji E; Hagiwara A; Yamagishi H
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1815-8. PubMed ID: 15553725
[TBL] [Abstract][Full Text] [Related]
35. Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma.
Hellerbrand C; Mühlbauer M; Wallner S; Schuierer M; Behrmann I; Bataille F; Weiss T; Schölmerich J; Bosserhoff AK
Carcinogenesis; 2006 Jan; 27(1):64-72. PubMed ID: 16081515
[TBL] [Abstract][Full Text] [Related]
36. Tyrosine kinase inhibitor PTK/ZK enhances the antitumor effects of interferon-α/5-fluorouracil therapy for hepatocellular carcinoma cells.
Murakami M; Kobayashi S; Marubashi S; Tomimaru Y; Noda T; Wada H; Eguchi H; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
Ann Surg Oncol; 2011 Feb; 18(2):589-96. PubMed ID: 20811948
[TBL] [Abstract][Full Text] [Related]
37. Sorafenib enhances the chemotherapeutic efficacy of S-1 against hepatocellular carcinoma through downregulation of transcription factor E2F-1.
Zhai JM; Yin XY; Lai YR; Hou X; Cai JP; Hao XY; Liang LJ; Zhang LJ
Cancer Chemother Pharmacol; 2013 May; 71(5):1255-64. PubMed ID: 23435877
[TBL] [Abstract][Full Text] [Related]
38. Interferon-alpha in combination with chemotherapy has potent antiangiogenic properties in an orthotopic mouse model for pancreatic adenocarcinoma.
Zhu Y; Tibensky I; Schmidt J; Hackert T; Ryschich E; Jäger D; Büchler MW; Märten A
J Immunother; 2008 Jan; 31(1):28-33. PubMed ID: 18157009
[TBL] [Abstract][Full Text] [Related]
39. Expression level of Bcl-XL critically affects sensitivity of hepatocellular carcinoma cells to LIGHT-enhanced and interferon-gamma-induced apoptosis.
Li J; Shen F; Wu D; Wei LX; Wang YZ; Shi LH; Zou Y; Wu MC
Oncol Rep; 2007 May; 17(5):1067-75. PubMed ID: 17390046
[TBL] [Abstract][Full Text] [Related]
40. Effect of a new adjuvant systemic interferon alpha, 5-fluorouracil and cisplatin on advanced hepatocellular carcinoma with macroscopic portal invasion.
Imura S; Ikemoto T; Morine Y; Fujii M; Miyake H; Tashiro S; Shimada M
Hepatogastroenterology; 2008; 55(82-83):615-20. PubMed ID: 18613419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
